Lung cancer

Osimertinib 80mg Tablet

Composition: Osimertinib

Manufacturer: AstraZeneca

Dosage: 80mg

Description

Third-generation EGFR inhibitor for non-small cell lung cancer with EGFR mutation. Reduces the risk of recurrence by 80%.

Prescription required: This medication requires a valid prescription.